SINOVAC BIOTECH LTD. - Common Shares (SVA)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Shares
Symbol
SVA on Nasdaq
Shares outstanding
71,858,757
Price per share
$6.47
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
8,982,045
Total reported value
$224,989,943
% of total 13F portfolios
0%
Share change
-1,311,686
Value change
-$843,804
Avg buy value change
0%
Avg sell value change
-0%
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SINOVAC BIOTECH LTD. - Common Shares (SVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
1Globe Capital LLC 32% 0% 18,515,315 0% 1Globe Capital LLC 07 Jul 2025
SAIF Partners IV L.P. 15% 0% 10,780,820 0% SAIF Partners IV L.P. 10 Jul 2025
WEIDONG YIN 8.8% 0% 6,359,500 0% Weidong Yin 10 Jul 2025
Advantech Capital L.P. 8.1% 0% 5,851,423 0% Advantech Capital L.P. 08 Jul 2025
Vivo Capital VIII, LLC 6.3% 0% 4,541,764 0% Vivo Capital IX, LLC 11 Jul 2025
Vivo Capital IX, LLC 6.3% $293,522,587 4,539,456 Vivo Capital IX, LLC 17 Mar 2025
As of 30 Sep 2025, SINOVAC BIOTECH LTD. - Common Shares (SVA) has 8 institutional shareholders filing 13F forms. They hold 8,982,045 shares. of 71,858,757 outstanding shares (12%) .

Top 9 institutional shareholders own 12% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Vivo Capital, LLC 8.2% 5,903,000 0% 3.1% $38,192,410
ORBIMED ADVISORS LLC 3.8% 2,718,735 0% 4.4% $184,466,170
Neumann Advisory Hong Kong Ltd 0.44% 315,586 0% 0.52% $2,042,000
WELLS FARGO & COMPANY/MN 0.02% 16,876 +0.15% 0% $109,188
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.02% 16,430 0% 0% $106,302
MORGAN STANLEY 0.01% 9,144 +9.6% 0% $59,161
UBS Group AG 0% 2,222 +0.41% 0% $14,376
Horizon Investments, LLC 0% 52 0% 0% $336
RENAISSANCE TECHNOLOGIES LLC 0% 0 -100% $0

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 315,586 $2,042,000 647.05% 1
2025 Q3 8,982,045 $224,989,943 -$843,804 647% 8
2025 Q2 10,293,731 $375,364,173 +$39,325,577 647% 9
2025 Q1 3,034,321 $336,038,595 6,466.03% 2
2024 Q4 3,034,321 $336,038,595 -$76,346,336 6,466.03% 2
2024 Q3 14,834,373 $418,388,336 -$1,189,080 647.03% 4
2024 Q2 13,494,548 $79,577,415 -$1,059,870 647% 10
2024 Q1 12,345,841 $79,877,748 +$77,790,616 647% 11
2023 Q4 315,638 $2,042,336 -$39,591,820 646.6% 2
2023 Q3 6,441,809 $41,678,662 -$244,074 647% 12
2023 Q2 579,502 $3,749,736 +$1,707,737 647% 12
2023 Q1 8,618,735 $955,369,410 $0 11,467.91% 2
2022 Q4 2,718,735 $340,000,000 -$2,141,005 12,505.82% 1
2022 Q3 6,546,422 $42,356,000 -$54,925 647.09% 11
2022 Q2 6,551,143 $42,387,000 +$1,576,005 647.36% 11
2022 Q1 6,307,855 $41,615,000 -$2,445,076 647.32% 6
2021 Q4 6,685,746 $43,256,000 -$4,571 646.97% 10
2021 Q3 11,921,582 $123,299,006 +$17,051 647.05% 17
2021 Q2 17,485,403 $448,703,006 +$66,457 647.03% 16
2021 Q1 19,851,004 $450,197,798 +$19,000 646.97% 16
2020 Q4 0 $0 -$3,000 0
2020 Q3 6,565,521 $42,480,000 -$12,370 647.07% 12
2020 Q2 6,567,434 $42,492,000 -$441,508 647.07% 12
2020 Q1 9,475,375 $60,086,177 +$38,176,000 647.05% 15
2019 Q4 22,374 $55,000 $0 245.82% 1
2019 Q3 22,374 $55,000 $0 245.82% 1
2019 Q2 0 $0 -$209,001 0
2019 Q1 11,865,978 $76,775,000 -$563,851 647.09% 19
2018 Q4 12,055,479 $83,665,328 -$1,516,079 694% 27
2018 Q3 12,161,097 $92,655,144 +$44,000,946 762.01% 27
2018 Q2 6,388,797 $47,657,952 -$3,325,538 745.87% 27
2018 Q1 6,825,579 $58,765,332 -$771,810 860.82% 28
2017 Q4 7,195,807 $56,704,456 -$4,237,010 787.95% 31
2017 Q3 18,130,684 $127,807,000 +$4,504,848 704.06% 34
2017 Q2 17,497,550 $118,106,000 -$9,432,684 674.85% 38
2017 Q1 18,903,143 $108,310,000 -$16,467,435 572.58% 35
2016 Q4 21,710,524 $128,091,000 -$2,317,441 590% 36
2016 Q3 11,345,665 $66,941,000 -$3,521,103 590.07% 36
2016 Q2 11,939,991 $70,801,000 -$990,272 592.93% 35
2016 Q1 12,095,039 $77,282,000 -$2,866,893 638.93% 33
2015 Q4 12,667,119 $72,453,000 -$3,331,199 571.97% 35
2015 Q3 13,163,626 $66,868,000 +$3,249,257 507.98% 31
2015 Q2 12,666,156 $66,493,675 +$430,399 524.97% 31
2015 Q1 12,615,535 $62,556,816 -$1,441,460 495.5% 37
2014 Q4 12,882,608 $67,344,058 -$773,287 522.99% 42
2014 Q3 12,940,762 $62,239,531 -$3,160,360 481.01% 42
2014 Q2 13,183,464 $74,347,660 -$7,915,206 564.02% 50
2014 Q1 14,475,921 $104,125,600 +$13,449,678 719.9% 50